This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Jan Terje Andersen, Ph.D.
Professor, University of Oslo and Group Leader at Oslo University Hospital
Speaker

Profile

Andersen is professor in biomedical innovation at University of Oslo, and a research group leader at Oslo University Hospital. He is heading the Laboratory of Adaptive Immunity and Homeostasis, which is a member of PRIMA - a Center of Excellence in Precision Immunotherapy. His lab is studying the cellular processes and molecular interplay underlying the functions of the two most abundant proteins in blood, albumin and IgG. By combining structural and biophysical approaches with cellular and in vivo studies, the in-depth knowledge is used in design of novel molecules with improved functions. The lab is extensively collaborating with biotech and pharmaceutical companies. Andersen has obtained the Fridtjof Nansen Prize for Early Career Achievements and a Distinguished Innovator Grant from Novo Nordisk Foundation and is a member of the Norwegian Academy of Science and Letters. He is also a co-founder of Authera AS.

Agenda Sessions

  • Co-Chairs' Remarks

    08:00